Inoviem Scientific, a contract research biotech (CRB), has secured funding of $693k from Cap Innov’Est, the French public investment bank Bpifrance and its own banks, as well as a $107k grant from Strasbourg Eurométropole. Inoviem has already received funding of more than $1.07 million in 2015, from Cap Innov’Est and Bpifrance. With this new financing, the company has already invested part of the funding in fitting out six laboratories to expand and enhance the range of services offered. Afte...